© Centrient Pharmaceuticals

Centrient Pharmaceuticals: New CEO

Ex-Sandoz Head of Global Franchises Rex Clements is taking over as CEO of Centrient Pharmaceuticals. Erstwhile Centrient CEO Karl Rotthier has decided to step down, the company said.

Clements, who holds a Master of Business Administration from the University of Pennsylvania, worked for Sandoz since 2011. Before that, he was a consultant at McKinsey &Co. At Centrient, Clements will have the mandate to drive and execute the strategy defined by the Supervisory Board of Directors and the Executive Committee, pursuing the growth trajectory the company has already set in motion.

Rotterdam-based Centrient Pharmaceuticals focusses on the production and commercialisation of sustainable antibiotics, next-generation statins and anti-fungals.